We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Untitled Letter for Avodart TV Spot
FDA Issues Untitled Letter for Avodart TV Spot
March 6, 2009
A TV commercial that claims GlaxoSmithKline’s (GSK) Avodart is the only medicine that treats the cause of urinary symptoms associated with an enlarged prostate was cited by the FDA for allegedly making misleading claims and overstating the product’s efficacy.